Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study
暂无分享,去创建一个
C. Flohr | Hidetoshi Takahashi | G. Chan | C. Feeney | H. Valdez | M. Dibonaventura | R. Rojo | S. Barbarot | L. Eichenfield | Z. Szalai | R. Sidbury | Z. Yao | Fan Zhang | R. Galus